antiplatelet agent

antiplatelet agent

Therapeutics Any agent–eg, aspirin, that ↓ platelet clumping and clotting

an·ti·plate·let a·gent

(an'tē-plāt'lĕt ā'jĕnt)
Agent that inhibits platelet aggregation and thus reduces the risk of thrombus formation.
Mentioned in ?
References in periodicals archive ?
Aspirin is economically priced antiplatelet agent which is extremely safe and effective.
Long term use of Low Dose Aspirin Therapy is quite safe and effective in various medical disorders - Prof. Akbar Chaudhry
First, patients received even one dosage of antiplatelet agent within 90 days were enrolled in this study.
Effect of prior antiplatelet therapy on major adverse cardiac events in patients diagnosed with infective endocarditis: Population-based retrospective cohort study
Aspirin inhibits platelet cyclooxygenase and thromboxane A2 and has been the most widely used antiplatelet agent. Dipyridamole is an inhibitor of phosphodiesterase.
TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
Looking at all patients taking warfarin (regardless of whether or not they were also taking an NSAID or antiplatelet agent), PPI co-therapy reduced the risk of hospitalization for upper GI bleeding by 24% (adjusted hazard ratio [HR]=0.76; 95% confidence interval [CI], 0.63 to 0.91), which translates into 29 fewer hospitalizations per 10,000 person-years.
The benefits--and limits--of PPIs with warfarin regimens
When a patient is on an anticoagulant or antiplatelet agent, it takes longer for primary hemostasis to occur; subsequently bleeding time is prolonged.
Oral anticoagulants and dental procedures: COURSE# 1208 (AGD# 016)-2 CE credits
It proposed a clinical response to Clopidogrel, an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease.
Lebanese students win Grand Award in Intel science contest
In this sub analysis for a new antiplatelet agent, this combination therapy did not prove to be useful, on the contrary, it produced more harm.
Is Vorapaxar a safe and effective antiplatelet agent for patients with prior Ischaemic Stroke receiving standard antiplatelet therapy?
Other combinations such as oral anticoagulation, and 1 antiplatelet agent or DAPT alone were less commonly selected.
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine/Perkutan koroner girisimden sonra uclu antitrombotik tedavi (aspirin, clopidogrel ve oral antikoagulan): Kisiye ozel yaklasim gereksinimi
Ticagrelor: A Novel Reversible Oral Antiplatelet Agent. Cardiol Rev.
Newer antiplatelet and antithrombotic drugs on the horizon
A large clinical trial (n=1358) involving hospitalized patients admitted with an acute coronary syndrome placed patients into three groups: those who had never taken an oral antiplatelet agent [nonusers] (n=930), those with a history of prior use (n=355) and those who had recently discontinued use (n=73).
2011 drug update: revisiting medications for reducing cardiovascular risk

Medical browser ?
Full browser ?